Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_assertion type Assertion NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_head.
- NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_assertion description "[While CXCR4 demonstrated significant upregulation in both tumour entities, IHC analysis revealed that the predominate cell type expressing CXCR4 in CRC is represented by tumour cells, whereas in CRLM the majority of positive CXCR4 signals is due to hepatocytes along the tumour invasion front.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_provenance.
- NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_assertion evidence source_evidence_literature NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_provenance.
- NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_assertion SIO_000772 18959627 NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_provenance.
- NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_assertion wasDerivedFrom befree-20140225 NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_provenance.
- NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_assertion wasGeneratedBy ECO_0000203 NP501077.RAMAKBx6-bDiTAAB5maIe363Emiv5M_sUIJWb0y_Z9ZS8130_provenance.